Specifically, it was found that 42.1% (n = 8) of the participants tested positive for both anti-ATPO and anti-ATG, and anti-ATPO alone was detected in 31.5% (n = 6) of the patients with type 1 diabetes (Table 2). The gene discussed is ATP5PO; the disease is type 1 diabetes mellitus.